As guided, the earnings came in roughly in the middle of the range of EUR 1.00 billion to EUR 1.05 billion. In the previous year, the company generated earnings of EUR 986 million.
Specialty chemicals company Lanxess had a successful fiscal year 2019 in an increasingly challenging economic environment. EBITDA pre exceptionals increased by 3.3 percent to EUR 1.019 billion. As guided, the earnings came in roughly in the middle of the range of EUR 1.00 billion to EUR 1.05 billion. In the previous year, the company generated earnings of EUR 986 million.
The strong results in the Advanced Intermediates, Specialty Additives and Performance Chemicals segments compensated for the decline in the Engineering Materials segment, due in particular to the weak demand from the automotive industry. Earnings were supported by advantageous exchange-rate effects, especially from the U.S. dollar. The EBITDA margin pre exceptionals for the full year reached 15.0 percent for the first time in the company's history, against 14.4 percent a year ago.
"In 2019's difficult economic environment, we withstood the first true test since our realignment. Lanxess is now more profitable and more stable than ever," said Matthias Zachert, Chairman of the Board of Management of Lanxess AG. "Even in these challenging times, we increased our margin to a new record high and further strengthened our financial base for new growth projects. In 2020, we will be increasingly devoted to the high-margin consumer protection business and new applications in the field of battery technology."
As of December 31, 2019, the Leather business unit is recognized as a discontinued operation. Sales and operating earnings - and the corresponding prior-year figures - were restated. As part of the strategic realignment the company intends to sell the business unit. Lanxess already disposed of the chrome chemicals business and its interest in the chrome ore mine in 2019.
At EUR 6.802 billion, Lanxess' group sales were around the previous year's level (EUR 6.824 billion). At EUR 240 million, net income from continuing operations was 14.9 percent down on the previous year's figure of EUR 282 million. It was reduced in particular by exceptional expenses for the realignment of the organometallics business.
Dividend to increase again
Also, in fiscal year 2019, the dividend is to be increased again. The Board of Management and Supervisory Board will propose a dividend of EUR 0.95 per share to the Annual Stockholders' Meeting on May 13, 2020. This would be around 6 percent more than in the previous year.
New segment: Consumer Protection
On its growth course, Lanxess intends to focus more sharply on consumer protection products and is therefore adjusting its segment structure, effective immediately. The Saltigo, Liquid Purification Technologies and Material Protection Products business units make up the new Consumer Protection segment. This segment's portfolio includes, for example, active ingredients for the agricultural and pharmaceutical industries, for insect repellents and disinfectants as well as technologies for processing and cleaning water.
"Our Consumer Protection products are characterized by attractive and stable growth rates. At the same time, our years of expertise in these often heavily regulated markets give us a competitive edge," said Zachert.
The Consumer Protection segment is replacing the former Performance Chemicals segment. At the same time, the Inorganic Pigments business unit is now part of the Advanced Intermediates segment. Reporting will be adjusted accordingly from the first quarter of 2020.
Lithium project: pilot facility test
The project for the commercial extraction of battery-grade lithium at the U.S. site in El Dorado, Arkansas, which Lanxess started with its partner Standard Lithium, has made further progress. At the site, Lanxess operates three plants manufacturing bromine products. The bromine is obtained from the brine extracted at the site, which also contains lithium. Standard Lithium has developed an innovative method for the extraction of high-purity lithium directly from brine. A pilot facility was set up on the plant premises and commissioned at the beginning of March 2020. Lanxess expects initial findings with regard to technological feasibility by mid-2020.
2020 outlook: operationally stable, but coronavirus burdens
Lanxess expects its operating business to remain stable in fiscal 2020. However, the company expects the effects of the coronavirus epidemic to impact the operating result by between EUR 50 million and EUR 100 million for the year as a whole. Overall, Lanxess therefore expects EBITDA pre exceptionals to be between EUR 900 million and EUR 1.0 billion. For the first quarter of 2020, the specialty chemicals company is currently anticipating charges of around EUR 20 million from the coronavirus epidemic.
END
